Apeloa Pharmaceutica...
SZSE:000739
¥ 17,55
+ ¥0,49 (2,87%)
17,55 ¥
+¥0,49 (2,87%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

¥0,67
Earnings Per Share
¥8,69
Revenue Per Share
25,41%
Gross Margin %
¥19,21 B
Market Cap
¥0,47 B
Long-Term Debt
Earnings Per Share
¥0,67
Revenue Per Share
¥8,69
Gross Margin %
25,41%
Market Cap
¥19,21 B
Long-Term Debt
¥0,47 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
EPS Earnings Per Share ¥0,77 ¥0,89 ¥0,90 ¥0,84 ¥0,81 ¥0,69 ¥0,47 ¥0,31 ¥0,22 ¥0,23 ¥0,18 ¥0,30
Earnings Earnings ¥866,95M ¥1,03B ¥1,05B ¥982,23M ¥954,60M ¥813,18M ¥553,90M ¥365,34M ¥259,27M ¥263,78M ¥206,44M ¥344,06M
RPS Revenue Per Share ¥0,00 ¥8,69 ¥10,38 ¥9,81 ¥9,02 ¥7,59 ¥6,69 ¥0,00 ¥5,41 ¥4,71 ¥4,16 ¥3,78 ¥3,69
Revenue Revenue ¥0,00M ¥9,78B ¥12,02B ¥11,47B ¥10,54B ¥8,94B ¥7,88B ¥0,00M ¥6,38B ¥5,55B ¥4,77B ¥4,34B ¥4,23B
OCF Operating Cash Flow ¥0,00M ¥1,22B ¥1,21B ¥1,03B ¥1,33B ¥611,75M ¥1,06B ¥0,00M ¥0,00M ¥209,80M ¥180,42M ¥441,16M ¥786,64M
FCF Free Cash Flow ¥0,00M ¥1,06B ¥756,52M ¥409,86M ¥821,87M ¥-86,30M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥0,00M ¥281,31M
OM Operating Margin 0,00% 8,97% 8,42% 9,39% 8,60% 10,73% 10,45% 8,37% 6,60% 6,72% 5,76% 5,65% 7,81%
GM % Gross Margin % 0,00% 25,41% 23,26% 24,86% 23,42% 26,43% 27,66% 31,91% 31,50% 30,36% 27,35% 26,66% 25,59%
FCFS Free Cash Flow Per Share ¥0,00 ¥0,72 ¥0,64 ¥0,34 ¥0,70 ¥-0,08 ¥0,63 ¥1,13 ¥0,64 ¥0,04 ¥-0,13 ¥-0,01 ¥0,23
LT Debt Long-Term Debt N/A ¥468,30M ¥70,05M ¥18,71M ¥249,62M ¥104,94M N/A N/A N/A N/A ¥179,98M ¥196,62M ¥172,00M
Sha. Stocks 1.158,44M 1.125,91M 1.158,44M 1.169,32M 1.169,32M 1.178,52M 1.178,52M 1.178,52M 1.178,52M 1.178,52M 1.146,87M 1.146,87M 1.146,87M
×